METTL3-dependent m6A modification of SLC2A1 mRNA regulates trophoblast migration and invasion associated with preeclampsia under hypoxic conditions
Аннотация
Preeclampsia (PE) is a serious pregnancy complication closely linked to trophoblast dysfunction. Recent studies highlight the importance of N⁶-methyladenosine (m⁶A) modification in placental development; however, its role in PE-associated trophoblast dysfunction remains poorly understood. This study aimed to elucidate the regulatory role of METTL3 in trophoblast cell function under hypoxia, a key pathological feature associated with preeclampsia, with a focus on its downstream target SLC2A1. A hypoxic model was established using HTR-8/SVneo trophoblast cells. METTL3 expression was evaluated using RT-qPCR and western blotting. METTL3 expression was modulated through siRNA-mediated knockdown and plasmid-based overexpression. Cell proliferation, apoptosis, migration, and invasion were evaluated using EdU, flow cytometry, and Transwell assays. With SLC2A1 as our pre-selected candidate, ENCORI and SRAMP databases were used to investigate METTL3 as a potential upstream m⁶A regulator of SLC2A1. The regulatory impact of METTL3 on SLC2A1 m⁶A methylation and mRNA stability was assessed through MeRIP-qPCR and actinomycin D assays. To confirm the functional relationship between METTL3 and SLC2A1, combined knockdown of METTL3 and SLC2A1 was performed. Hypoxic stimulation significantly upregulated METTL3 expression in HTR-8/SVneo cells. METTL3 silencing markedly enhanced trophoblast cell proliferation, migration, and invasion, while reducing apoptosis, whereas METTL3 overexpression produced the opposite effects. Mechanistically, METTL3 promoted m6A modification of SLC2A1 mRNA and accelerated its degradation, thereby suppressing SLC2A1 expression. Moreover, co-silencing SLC2A1 significantly attenuated the pro-proliferative and pro-migratory effects induced by METTL3 knockdown, suggesting that SLC2A1 functions as a critical downstream effector in METTL3-mediated regulation of trophoblast cell function. METTL3 is aberrantly upregulated under hypoxic conditions and suppresses the mRNA stability and expression of SLC2A1 through m⁶A modification, thereby inhibiting the proliferative and invasive capacities of trophoblast cells.